Journal of Diabetes Research / 2010 / Article / Tab 3

Research Article

Fenofibrate Treatment Enhances Antioxidant Status and Attenuates Endothelial Dysfunction in Streptozotocin-Induced Diabetic Rats

Table 3

Metabolic data for control and diabetic groups. Data are expressed as mean ± SEM of data obtained from 10 rats in each group. C: control; D: diabetes mellitus; FF: fenofibrate; TBARS: thiobarbituric acid reactive substances; MPO: myeloperoxidase; SOD: superoxide dismutase; TNF-α: tumor necrosis factor-alpha. * versus C; # versus DM.


Erythrocyte SOD (U/g hemoglobin)
Erythrocyte Catalase (U/g hemoglobin)
Liver SOD (U/mg protein)
Liver Catalase (U/mg protein)
Erythrocyte TBARS (nmol/g hemoglobin)
Liver TBARS (nmol/mg protein)
Aortic TBARS (nmol/mg protein)
Aortic MPO (U/g protein)
Serum TNF-α (pmol/L)
Serum Homocysteine (μmol/L)